AbbVie
ABBV
ABBV
2,959 hedge funds and large institutions have $166B invested in AbbVie in 2022 Q3 according to their latest regulatory filings, with 137 funds opening new positions, 1,299 increasing their positions, 1,154 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 2,995 → 2,959 (-36)
11% less capital invested
Capital invested by funds: $186B → $166B (-$20.1B)
16% less funds holding in top 10
Funds holding in top 10: 329 → 277 (-52)
Holders
2,959
Holding in Top 10
277
Calls
$2.32B
Puts
$2.05B
Top Buyers
| 1 | +$2.16B | |
| 2 | +$1.33B | |
| 3 | +$503M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$359M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$328M |
Top Sellers
| 1 | -$844M | |
| 2 | -$404M | |
| 3 | -$321M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$304M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$261M |